Search Results for 'amyris'

Amyris’ Sweet-‘N-High: Biotech pioneer sells farnesene plant to DSM, focuses on next-gen sweetener

Amyris’ Sweet-‘N-High: Biotech pioneer sells farnesene plant to DSM, focuses on next-gen sweetener

November 20, 2017 |

The nine month and Q3 2017 results are in for Amyris, and there’s reason for the long-suffering shareholder to take some near-Christmas cheer. YTD revenue is up more than 1/3 and product revenue has more than doubled. Guidance for year-end revenues was upped. The company has found a new deep-pocketed champion in DSM. But there […]

Read More

Making Renewables Mainstream: The Digest’s 2017 Multi-Slide Guide to Amyris

Making Renewables Mainstream: The Digest’s 2017 Multi-Slide Guide to Amyris

October 26, 2017 |

  We reported on Amyris’ progress recently in “The New Colossus aims to unlock its Golden Door” and in Two Up: Amyris, Queensland gamble on farnesene for SE Asia. Meanwhile, Amyris President of R&D Joel Cherry presented these illuminating slides on the company’s progress at ABLC 2017 in San Francisco.

Read More

Amyris announces second product development tie up with Royal DSM

Amyris announces second product development tie up with Royal DSM

September 26, 2017 |

In California, Amyris, Inc. announced that it has entered into a product development and production agreement for Vitamin A with Koninklijke DSM N.V. This marks the second such agreement between the two parties. DSM is partnering with Amyris to fund the development of the technology to produce Vitamin A on a cost-advantaged basis utilizing Amyris’s […]

Read More

From Project to Player: The Digest’s 2017 Multi-Slide Guide to Amyris

From Project to Player: The Digest’s 2017 Multi-Slide Guide to Amyris

September 21, 2017 |

In California, Amyris reported Q2 2017 revenues of $25.7M million, more than double the sales from 2016. The increase was driven by a major increase in product sales, primarily in the company’s personal care segment, as well as by significantly higher collaboration revenues. For many people, the key question is — what is Amyris becoming, and […]

Read More

Amyris posts 168% increase in revenue for 2017 Q2 over 2016 Q2

Amyris posts 168% increase in revenue for 2017 Q2 over 2016 Q2

August 12, 2017 |

In California, Amyris announced its net income of $620,000 and total revenue of $25.7 million for the second quarter, which was good news for investors who saw a 168% increase over the same period last year. Product sales were up over 159% from last year’s Q2 as well, with Biossance sales delivering outstanding results and […]

Read More

Amyris closes second $25 million tranche of financing

Amyris closes second $25 million tranche of financing

August 10, 2017 |

In California, Amyris, Inc. announced the closing of the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25-million investment from Koninklijke DSM N.V. with the remaining $25 million contributed by Vivo Capital. “We are pleased to have the support of […]

Read More

Amyris enters first production development and production agreement with DSM

Amyris enters first production development and production agreement with DSM

July 17, 2017 |

In California, Amyris announce it has entered into its first product development and production agreement with Koninklijke DSM N.V. (Royal DSM), the global science-based company active in health, nutrition and materials, to develop a food and nutrition molecule for which DSM is a major market provider. As part of the previously announced equity investment DSM […]

Read More

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

June 22, 2017 |

  The Digest discovered this hand-written lyric, we think written with a thumbnail dipped in biocrude, near Amyris headquarters in Emeryville, California. Somewhere north of Byron Bay where Cooktown orchids grow, and cane is ever-present and the Pioneer River flows, there’ll be a group of smarties along the coastal towns hawking tonnes of bio farnesene for a zillion yuan a […]

Read More

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

June 22, 2017 |

  The Digest discovered this hand-written lyric, we think written with a thumbnail dipped in biocrude, near Amyris headquarters in Emeryville, California. Somewhere north of Byron Bay where Cooktown orchids grow, and cane is ever-present and the Pioneer River flows there’ll be a group of smarties along the coastal towns hawking tonnes of bio farnesene for a zillion yuan a […]

Read More

Amyris and Queensland team on commercial-scale biorefineries

Amyris and Queensland team on commercial-scale biorefineries

June 20, 2017 |

In Australia, Amyris, Inc. and the Government of Queensland announced the next step in their plans to develop a leading industrial biotechnology hub in Southeast Asia. Plans call for developing a new production plant with support from local partners to produce Amyris’s sugar cane-based ingredient called farnesene, which is used in products including cosmetic emollients, […]

Read More